ArticleTranslational lung cancer research2026
Heterogeneous efficacy and predictors of response to immunotherapy in driver-mutant advanced NSCLC: a focus on EGFR and KRAS subtypes.
Yan Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.